- Record: found
- Abstract: not found
- Article: not found
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists
are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine
phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy
and acceptable safety against COVID-19 associated pneumonia in multicenter clinical
trials conducted in China. The drug is recommended to be included in the next version
of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused
by COVID-19 issued by the National Health Commission of the People's Republic of China
for treatment of COVID-19 infection in larger populations in the future.